Inspire Medical Systems, Inc. (INSP)

Market Cap	4.48B
Revenue (ttm)	570.19M
Net Income (ttm)	-32.77M
Shares Out	29.52M
EPS (ttm)	-1.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	468,860
Open	145.15
Previous Close	145.31
Day's Range	143.29 - 153.02
52-Week Range	123.27 - 330.00
Beta	1.47
Analysts	Strong Buy
Price Target	279.08 (+83.94%)
Earnings Date	Nov 7, 2023

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The co...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 3, 2018
• Employees: 755
• Stock Exchange: NYSE
• Ticker Symbol: INSP

Financial Performance

In 2022, INSP's revenue was $407.86 million, an increase of 74.75% compared to the previous year's $233.39 million. Losses were -$44.88 million, 6.75% more than in 2021.

Analyst Forecast

According to 14 analysts, the average rating for INSP stock is "Strong Buy." The 12-month stock price forecast is $279.08, which is an increase of 83.94% from the latest price.

Price Target

$279.08

(83.94% upside)

Analyst Consensus: Strong Buy